The global Kirschner Wire Market Growth Accelerated by Increased Adoption in Orthopedic and Traumatology Procedures

 


Kirschner wires, also known as K-wires, are thin surgical stainless steel wires used to hold together and support broken bones such as fractures until they heal. They help stabilizes and support fractures and breaks in small bones of hands, feet and facial structures. K-wires play a vital role in orthopedic procedures such as fixing fractures, bone grafting and reconstructive surgeries. The global market is driven by increasing incidence rates of fractures worldwide and growing number of orthopedic and traumatology procedures.

The global Kirschner Wire Market is estimated to be valued at US$ 2,135.2 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030.

Market key trends:
The global Kirschner wire market is expected to witness significant growth over the forecast period, owing to increased adoption in orthopedic and traumatology procedures. K-wires are extensively used to stabilize fractures in small hand and foot bones during related surgeries. With rising prevalence of bone fractures due to road accidents and injuries sustained during sports activities, the demand for orthopedic fixation devices including K-wires is growing. According to WHO, road accidents account for around 1.35 million deaths globally each year. Moreover, improved healthcare infrastructure and availability of advanced medical facilities for effective fracture treatment in developing nations will further augment the market growth over the coming years. However, availability of alternative treatments and slow global economic recovery due to COVID-19 pandemic may hamper the market expansion to some extent during the forecast period.


Segment Analysis
The global Kirschner wire market is dominated by the orthopedic surgery segment, which accounts for over 60% share of the overall market. Kirschner wires find extensive usage in surgeries such as fracture repair, external fixation, and management of various bone injuries. They allow surgeons to stabilize fractures by passing through bones or joints. The orthopedic surgery segment is expected to remain the dominant segment during the forecast period owing to the growing prevalence of fractures and musculoskeletal injuries worldwide.

Key Takeaways
The global Kirschner wire market is expected to witness high growth over the forecast period from 2023 to 2030. The global Kirschner Wire Market is estimated to be valued at US$ 2,135.2 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030.

North America is currently the dominant region, accounting for over 35% of the total market share. This is attributed to factors such as rising incidence of bone fractures and injuries, growing geriatric population, and presence of major market players in the region. The Asia Pacific region is projected to be the fastest-growing market owing to increasing healthcare expenditure, large patient pool, and rising awareness regarding orthopedic devices.

Key players operating in the Kirschner wire market are Stryker Corporation, Paragon 28 Inc, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Orthofix Medical Inc., Smith & Nephew plc, Medline Industries, Inc., Becton, Dickinson and Company, DePuy Synthes Companies (a subsidiary of Johnson & Johnson), Arthrex, Inc., Wright Medical Group N.V., Integra LifeSciences Corporation, KLS Martin Group, Acumed LLC and GPC Medical Ltd. Stryker Corporation holds the leading market share of over 20%, while Zimmer Biomet Holdings, Inc. and Smith & Nephew plc occupy around 15-18% share each. The key players are focusing on new product launches, partnerships, and geographic expansion strategies to strengthen their global footprint.

Comments

Post a Comment

Popular posts from this blog

Fibrinolytic Therapy is Anticipated to Witness Moderate Growth Owing to Rising Prevalence of Cardiovascular Diseases

Image
The global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period of 2023 to 2030. Fibrinolytic therapy, also called thrombolysis, involves the use of clot-busting drugs to dissolve blood clots and restore blood flow. Rising prevalence of cardiovascular diseases such as heart attacks and strokes has increased the demand for fibrinolytic drugs worldwide. Fibrinolytic therapy improves patient outcomes and recovery rates by dissolving the clots blocking arteries and restoring blood flow to tissues and organs. Key players operating in the fibrinolytic therapy market are Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Mitsub...
Read more

Intraocular Lens Market to Witness High Growth Due to Rising Prevalence of Cataract Across Globe

Image
Intraocular lens (IOL) is an artificial lens which is implanted inside eyes during cataract surgery to replace clouded eye lenses. IOL helps enhance vision and provides independence from glasses or contact lenses by helping patients restore clarity of vision. IOLs act as replacement for eye's natural crystalline lens after cataract removal. The global intraocular lens market is mainly driven by rising geriatric population suffering from age-related cataracts across the globe. Cataract is common age-related eye disease, affecting vision and quality of life of elderly people. As per the World Health Organization (WHO), cataracts are the leading cause of blindness globally affecting over 38 million population worldwide. Growing cases of cataract and demand for its minimally invasive surgeries are propelling market growth. The Global intraocular lens market is estimated to be valued at US$ 5,076.1 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to ...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more